nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—SST—hepatic artery—stomach cancer	0.0901	0.209	CbGeAlD
Cysteamine—SST—portal vein—stomach cancer	0.0783	0.181	CbGeAlD
Cysteamine—SST—myenteric nerve plexus—stomach cancer	0.0699	0.162	CbGeAlD
Cysteamine—SST—vagus nerve—stomach cancer	0.0466	0.108	CbGeAlD
Cysteamine—SST—vein—stomach cancer	0.045	0.104	CbGeAlD
Cysteamine—SST—blood vessel—stomach cancer	0.0143	0.0331	CbGeAlD
Cysteamine—SST—gall bladder—stomach cancer	0.0134	0.0311	CbGeAlD
Cysteamine—SST—hematopoietic system—stomach cancer	0.00761	0.0176	CbGeAlD
Cysteamine—SST—epithelium—stomach cancer	0.00696	0.0161	CbGeAlD
Cysteamine—SST—smooth muscle tissue—stomach cancer	0.0067	0.0155	CbGeAlD
Cysteamine—SST—pancreas—stomach cancer	0.0062	0.0143	CbGeAlD
Cysteamine—MPO—blood vessel—stomach cancer	0.00576	0.0133	CbGeAlD
Cysteamine—SST—lymphoid tissue—stomach cancer	0.00536	0.0124	CbGeAlD
Cysteamine—SST—digestive system—stomach cancer	0.00529	0.0122	CbGeAlD
Cysteamine—SST—endocrine gland—stomach cancer	0.00437	0.0101	CbGeAlD
Cysteamine—SST—liver—stomach cancer	0.00394	0.00912	CbGeAlD
Cysteamine—MPO—hematopoietic system—stomach cancer	0.00306	0.00709	CbGeAlD
Cysteamine—SST—lymph node—stomach cancer	0.00302	0.00699	CbGeAlD
Cysteamine—MPO—epithelium—stomach cancer	0.0028	0.00648	CbGeAlD
Cysteamine—MPO—pancreas—stomach cancer	0.0025	0.00577	CbGeAlD
Cysteamine—MPO—lymphoid tissue—stomach cancer	0.00216	0.00499	CbGeAlD
Cysteamine—MPO—digestive system—stomach cancer	0.00213	0.00493	CbGeAlD
Cysteamine—MPO—bone marrow—stomach cancer	0.00196	0.00455	CbGeAlD
Cysteamine—MPO—endocrine gland—stomach cancer	0.00176	0.00408	CbGeAlD
Cysteamine—MPO—liver—stomach cancer	0.00159	0.00367	CbGeAlD
Cysteamine—MPO—lymph node—stomach cancer	0.00122	0.00282	CbGeAlD
Cysteamine—MPO—Vitamin B12 Metabolism—ALB—stomach cancer	0.000954	0.00337	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—HTR1A—stomach cancer	0.00095	0.00335	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	0.000946	0.00334	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—CDK4—stomach cancer	0.000939	0.00331	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—ADRB1—stomach cancer	0.000927	0.00327	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—ANXA1—stomach cancer	0.000918	0.00324	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—HRH4—stomach cancer	0.00091	0.00321	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—KISS1—stomach cancer	0.000893	0.00315	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—ADRB1—stomach cancer	0.000889	0.00313	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—HRH4—stomach cancer	0.000872	0.00308	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—KISS1—stomach cancer	0.000856	0.00302	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—PPARG—stomach cancer	0.000853	0.00301	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—MTHFR—stomach cancer	0.000846	0.00298	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—STAT3—stomach cancer	0.000842	0.00297	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—CXCL8—stomach cancer	0.000832	0.00293	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—KISS1—stomach cancer	0.000811	0.00286	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—IL1B—stomach cancer	0.000798	0.00281	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—APOA1—stomach cancer	0.000779	0.00275	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—SERPINE1—stomach cancer	0.000778	0.00274	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—KISS1—stomach cancer	0.000777	0.00274	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—IL1B—stomach cancer	0.000777	0.00274	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—ALB—stomach cancer	0.000776	0.00274	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—JUN—stomach cancer	0.000773	0.00273	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—SERPINE1—stomach cancer	0.000769	0.00271	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—RGS2—stomach cancer	0.000768	0.00271	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—GAST—stomach cancer	0.000768	0.00271	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—ADRB2—stomach cancer	0.000751	0.00265	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GLI3—stomach cancer	0.000743	0.00262	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—KISS1R—stomach cancer	0.000743	0.00262	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—RGS2—stomach cancer	0.000736	0.0026	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—GAST—stomach cancer	0.000736	0.0026	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—TNF—stomach cancer	0.000729	0.00257	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—ADRB2—stomach cancer	0.00072	0.00254	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—KISS1R—stomach cancer	0.000713	0.00251	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GLI3—stomach cancer	0.000713	0.00251	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—CXCL8—stomach cancer	0.00071	0.0025	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—RBP1—stomach cancer	0.000709	0.0025	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—RGS2—stomach cancer	0.000697	0.00246	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—GAST—stomach cancer	0.000697	0.00246	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CXCL8—stomach cancer	0.000681	0.0024	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—RBP1—stomach cancer	0.00068	0.0024	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—VEGFA—stomach cancer	0.000675	0.00238	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—RGS2—stomach cancer	0.000668	0.00236	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—GAST—stomach cancer	0.000668	0.00236	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—PIK3CA—stomach cancer	0.000664	0.00234	CbGpPWpGaD
Cysteamine—Nervous system disorder—Irinotecan—stomach cancer	0.000639	0.00225	CcSEcCtD
Cysteamine—Eye pain—Doxorubicin—stomach cancer	0.000633	0.00223	CcSEcCtD
Cysteamine—MPO—Folate Metabolism—IL1B—stomach cancer	0.000632	0.00223	CbGpPWpGaD
Cysteamine—Lethargy—Epirubicin—stomach cancer	0.00063	0.00222	CcSEcCtD
Cysteamine—Confusional state—Fluorouracil—stomach cancer	0.000629	0.00221	CcSEcCtD
Cysteamine—Urinary tract disorder—Docetaxel—stomach cancer	0.000626	0.0022	CcSEcCtD
Cysteamine—Mood swings—Methotrexate—stomach cancer	0.000625	0.0022	CcSEcCtD
Cysteamine—Anaphylactic shock—Fluorouracil—stomach cancer	0.000624	0.00219	CcSEcCtD
Cysteamine—Connective tissue disorder—Docetaxel—stomach cancer	0.000623	0.00219	CcSEcCtD
Cysteamine—Urethral disorder—Docetaxel—stomach cancer	0.000621	0.00218	CcSEcCtD
Cysteamine—Anorexia—Irinotecan—stomach cancer	0.000621	0.00218	CcSEcCtD
Cysteamine—Ataxia—Methotrexate—stomach cancer	0.000621	0.00218	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—SERPINE1—stomach cancer	0.000618	0.00218	CbGpPWpGaD
Cysteamine—Pain in extremity—Epirubicin—stomach cancer	0.000618	0.00217	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—ALB—stomach cancer	0.000617	0.00218	CbGpPWpGaD
Cysteamine—Nervous system disorder—Fluorouracil—stomach cancer	0.000612	0.00215	CcSEcCtD
Cysteamine—Liver function test abnormal—Methotrexate—stomach cancer	0.000609	0.00214	CcSEcCtD
Cysteamine—Affect lability—Epirubicin—stomach cancer	0.000608	0.00214	CcSEcCtD
Cysteamine—Urinary tract disorder—Capecitabine—stomach cancer	0.000606	0.00213	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—JUN—stomach cancer	0.000605	0.00213	CbGpPWpGaD
Cysteamine—Connective tissue disorder—Capecitabine—stomach cancer	0.000603	0.00212	CcSEcCtD
Cysteamine—Urethral disorder—Capecitabine—stomach cancer	0.000601	0.00212	CcSEcCtD
Cysteamine—SST—G alpha (i) signalling events—CXCL8—stomach cancer	0.000599	0.00211	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—CDKN2A—stomach cancer	0.000599	0.00211	CbGpPWpGaD
Cysteamine—Anorexia—Fluorouracil—stomach cancer	0.000594	0.00209	CcSEcCtD
Cysteamine—MPO—IL23-mediated signaling events—IL6—stomach cancer	0.000588	0.00207	CbGpPWpGaD
Cysteamine—Mood swings—Epirubicin—stomach cancer	0.000585	0.00206	CcSEcCtD
Cysteamine—Lethargy—Doxorubicin—stomach cancer	0.000583	0.00205	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—AGTR2—stomach cancer	0.000582	0.00205	CbGpPWpGaD
Cysteamine—Ataxia—Epirubicin—stomach cancer	0.000581	0.00204	CcSEcCtD
Cysteamine—SST—SIDS Susceptibility Pathways—TNF—stomach cancer	0.000579	0.00204	CbGpPWpGaD
Cysteamine—Somnolence—Irinotecan—stomach cancer	0.000579	0.00204	CcSEcCtD
Cysteamine—SST—Signaling Pathways—WWOX—stomach cancer	0.000578	0.00204	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—F2R—stomach cancer	0.000575	0.00203	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—CXCL8—stomach cancer	0.000574	0.00203	CbGpPWpGaD
Cysteamine—Dehydration—Epirubicin—stomach cancer	0.000574	0.00202	CcSEcCtD
Cysteamine—Dyspepsia—Irinotecan—stomach cancer	0.000573	0.00202	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—MAPK8—stomach cancer	0.000573	0.00202	CbGpPWpGaD
Cysteamine—Immune system disorder—Docetaxel—stomach cancer	0.000572	0.00201	CcSEcCtD
Cysteamine—Pain in extremity—Doxorubicin—stomach cancer	0.000572	0.00201	CcSEcCtD
Cysteamine—Liver function test abnormal—Epirubicin—stomach cancer	0.00057	0.00201	CcSEcCtD
Cysteamine—Decreased appetite—Irinotecan—stomach cancer	0.000566	0.00199	CcSEcCtD
Cysteamine—MPO—Vitamin B12 Metabolism—TNF—stomach cancer	0.000564	0.00199	CbGpPWpGaD
Cysteamine—Affect lability—Doxorubicin—stomach cancer	0.000563	0.00198	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000562	0.00198	CcSEcCtD
Cysteamine—Fatigue—Irinotecan—stomach cancer	0.000561	0.00197	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—PTGS2—stomach cancer	0.00056	0.00198	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—HTR1A—stomach cancer	0.00056	0.00198	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—AGTR2—stomach cancer	0.000558	0.00197	CbGpPWpGaD
Cysteamine—Constipation—Irinotecan—stomach cancer	0.000557	0.00196	CcSEcCtD
Cysteamine—Mental disorder—Docetaxel—stomach cancer	0.000555	0.00195	CcSEcCtD
Cysteamine—Somnolence—Fluorouracil—stomach cancer	0.000554	0.00195	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—WWOX—stomach cancer	0.000554	0.00195	CbGpPWpGaD
Cysteamine—Immune system disorder—Capecitabine—stomach cancer	0.000554	0.00195	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—F2R—stomach cancer	0.000552	0.00195	CbGpPWpGaD
Cysteamine—Malnutrition—Docetaxel—stomach cancer	0.000552	0.00194	CcSEcCtD
Cysteamine—Erythema—Docetaxel—stomach cancer	0.000552	0.00194	CcSEcCtD
Cysteamine—Dyspepsia—Fluorouracil—stomach cancer	0.000549	0.00193	CcSEcCtD
Cysteamine—Decreased appetite—Fluorouracil—stomach cancer	0.000542	0.00191	CcSEcCtD
Cysteamine—Mood swings—Doxorubicin—stomach cancer	0.000541	0.0019	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—ANXA1—stomach cancer	0.000541	0.00191	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—PTGS2—stomach cancer	0.00054	0.0019	CbGpPWpGaD
Cysteamine—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000538	0.00189	CcSEcCtD
Cysteamine—Ataxia—Doxorubicin—stomach cancer	0.000537	0.00189	CcSEcCtD
Cysteamine—SST—Signaling Pathways—HRH4—stomach cancer	0.000537	0.0019	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—WIF1—stomach cancer	0.000537	0.0019	CbGpPWpGaD
Cysteamine—Mental disorder—Capecitabine—stomach cancer	0.000537	0.00189	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—HTR1A—stomach cancer	0.000537	0.00189	CbGpPWpGaD
Cysteamine—Feeling abnormal—Irinotecan—stomach cancer	0.000537	0.00189	CcSEcCtD
Cysteamine—Erythema—Capecitabine—stomach cancer	0.000534	0.00188	CcSEcCtD
Cysteamine—Malnutrition—Capecitabine—stomach cancer	0.000534	0.00188	CcSEcCtD
Cysteamine—Gastrointestinal pain—Irinotecan—stomach cancer	0.000532	0.00187	CcSEcCtD
Cysteamine—Dehydration—Doxorubicin—stomach cancer	0.000532	0.00187	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—CDKN1B—stomach cancer	0.000531	0.00187	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—AGTR2—stomach cancer	0.000528	0.00186	CbGpPWpGaD
Cysteamine—Liver function test abnormal—Doxorubicin—stomach cancer	0.000528	0.00186	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—ADRB1—stomach cancer	0.000524	0.00185	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—F2R—stomach cancer	0.000522	0.00184	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—ANXA1—stomach cancer	0.000519	0.00183	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HRH4—stomach cancer	0.000515	0.00182	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—WIF1—stomach cancer	0.000515	0.00182	CbGpPWpGaD
Cysteamine—Body temperature increased—Irinotecan—stomach cancer	0.000515	0.00181	CcSEcCtD
Cysteamine—Abdominal pain—Irinotecan—stomach cancer	0.000515	0.00181	CcSEcCtD
Cysteamine—Feeling abnormal—Fluorouracil—stomach cancer	0.000514	0.00181	CcSEcCtD
Cysteamine—Anaemia—Docetaxel—stomach cancer	0.00051	0.00179	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—HTR1A—stomach cancer	0.000509	0.00179	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—AGTR2—stomach cancer	0.000507	0.00179	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—CCND1—stomach cancer	0.000506	0.00178	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—ADRB1—stomach cancer	0.000502	0.00177	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—IL1B—stomach cancer	0.000502	0.00177	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—F2R—stomach cancer	0.000501	0.00177	CbGpPWpGaD
Cysteamine—Tremor—Capecitabine—stomach cancer	0.0005	0.00176	CcSEcCtD
Cysteamine—Renal failure—Methotrexate—stomach cancer	0.0005	0.00176	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PRKAB1—stomach cancer	0.000496	0.00175	CbGpPWpGaD
Cysteamine—Urticaria—Fluorouracil—stomach cancer	0.000495	0.00174	CcSEcCtD
Cysteamine—Leukopenia—Docetaxel—stomach cancer	0.000494	0.00174	CcSEcCtD
Cysteamine—Anaemia—Capecitabine—stomach cancer	0.000494	0.00174	CcSEcCtD
Cysteamine—Body temperature increased—Fluorouracil—stomach cancer	0.000493	0.00173	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—ANXA1—stomach cancer	0.000491	0.00173	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—CDKN1A—stomach cancer	0.00049	0.00173	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—HTR1A—stomach cancer	0.000488	0.00172	CbGpPWpGaD
Cysteamine—Hypersensitivity—Irinotecan—stomach cancer	0.00048	0.00169	CcSEcCtD
Cysteamine—SST—Signaling Pathways—RNF43—stomach cancer	0.000479	0.00169	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—KISS1—stomach cancer	0.000479	0.00169	CbGpPWpGaD
Cysteamine—Leukopenia—Capecitabine—stomach cancer	0.000478	0.00168	CcSEcCtD
Cysteamine—Convulsion—Docetaxel—stomach cancer	0.000478	0.00168	CcSEcCtD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000476	0.00168	CbGpPWpGaD
Cysteamine—Hypertension—Docetaxel—stomach cancer	0.000476	0.00167	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—ADRB1—stomach cancer	0.000476	0.00168	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PRKAB1—stomach cancer	0.000475	0.00168	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—ANXA1—stomach cancer	0.000471	0.00166	CbGpPWpGaD
Cysteamine—Renal failure—Epirubicin—stomach cancer	0.000468	0.00165	CcSEcCtD
Cysteamine—Asthenia—Irinotecan—stomach cancer	0.000467	0.00164	CcSEcCtD
Cysteamine—SST—SIDS Susceptibility Pathways—IL6—stomach cancer	0.000467	0.00165	CbGpPWpGaD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000466	0.00164	CcSEcCtD
Cysteamine—Hypertension—Capecitabine—stomach cancer	0.000461	0.00162	CcSEcCtD
Cysteamine—Hypersensitivity—Fluorouracil—stomach cancer	0.000459	0.00162	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—RNF43—stomach cancer	0.000459	0.00162	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—KISS1—stomach cancer	0.000459	0.00162	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—TNF—stomach cancer	0.000459	0.00162	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000457	0.00161	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—ADRB1—stomach cancer	0.000456	0.00161	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—IL6—stomach cancer	0.000455	0.0016	CbGpPWpGaD
Cysteamine—Confusional state—Docetaxel—stomach cancer	0.000454	0.0016	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000451	0.00159	CcSEcCtD
Cysteamine—Urinary tract disorder—Methotrexate—stomach cancer	0.000451	0.00159	CcSEcCtD
Cysteamine—Anaphylactic shock—Docetaxel—stomach cancer	0.00045	0.00158	CcSEcCtD
Cysteamine—Discomfort—Capecitabine—stomach cancer	0.000449	0.00158	CcSEcCtD
Cysteamine—Urethral disorder—Methotrexate—stomach cancer	0.000448	0.00157	CcSEcCtD
Cysteamine—Diarrhoea—Irinotecan—stomach cancer	0.000446	0.00157	CcSEcCtD
Cysteamine—Nervous system disorder—Docetaxel—stomach cancer	0.000441	0.00155	CcSEcCtD
Cysteamine—Confusional state—Capecitabine—stomach cancer	0.000439	0.00155	CcSEcCtD
Cysteamine—Skin disorder—Docetaxel—stomach cancer	0.000437	0.00154	CcSEcCtD
Cysteamine—Renal failure—Doxorubicin—stomach cancer	0.000433	0.00152	CcSEcCtD
Cysteamine—Dizziness—Irinotecan—stomach cancer	0.000431	0.00151	CcSEcCtD
Cysteamine—Anorexia—Docetaxel—stomach cancer	0.000429	0.00151	CcSEcCtD
Cysteamine—Nervous system disorder—Capecitabine—stomach cancer	0.000427	0.0015	CcSEcCtD
Cysteamine—SST—Signaling Pathways—FST—stomach cancer	0.000427	0.00151	CbGpPWpGaD
Cysteamine—Diarrhoea—Fluorouracil—stomach cancer	0.000427	0.0015	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—ADRB2—stomach cancer	0.000424	0.0015	CbGpPWpGaD
Cysteamine—Skin disorder—Capecitabine—stomach cancer	0.000423	0.00149	CcSEcCtD
Cysteamine—Urinary tract disorder—Epirubicin—stomach cancer	0.000422	0.00148	CcSEcCtD
Cysteamine—Connective tissue disorder—Epirubicin—stomach cancer	0.00042	0.00148	CcSEcCtD
Cysteamine—Urethral disorder—Epirubicin—stomach cancer	0.000419	0.00147	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—HBEGF—stomach cancer	0.000418	0.00147	CbGpPWpGaD
Cysteamine—Anorexia—Capecitabine—stomach cancer	0.000415	0.00146	CcSEcCtD
Cysteamine—Vomiting—Irinotecan—stomach cancer	0.000414	0.00146	CcSEcCtD
Cysteamine—Immune system disorder—Methotrexate—stomach cancer	0.000412	0.00145	CcSEcCtD
Cysteamine—Dizziness—Fluorouracil—stomach cancer	0.000412	0.00145	CcSEcCtD
Cysteamine—SST—Signaling Pathways—GAST—stomach cancer	0.000412	0.00145	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—RGS2—stomach cancer	0.000412	0.00145	CbGpPWpGaD
Cysteamine—Rash—Irinotecan—stomach cancer	0.000411	0.00144	CcSEcCtD
Cysteamine—Dermatitis—Irinotecan—stomach cancer	0.00041	0.00144	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—FST—stomach cancer	0.000409	0.00144	CbGpPWpGaD
Cysteamine—Headache—Irinotecan—stomach cancer	0.000408	0.00143	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—ADRB2—stomach cancer	0.000407	0.00144	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—MYC—stomach cancer	0.000406	0.00143	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—TP53—stomach cancer	0.000404	0.00143	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—HBEGF—stomach cancer	0.0004	0.00141	CbGpPWpGaD
Cysteamine—Somnolence—Docetaxel—stomach cancer	0.0004	0.00141	CcSEcCtD
Cysteamine—Mental disorder—Methotrexate—stomach cancer	0.0004	0.00141	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—TP53—stomach cancer	0.000399	0.00141	CbGpPWpGaD
Cysteamine—Erythema—Methotrexate—stomach cancer	0.000397	0.0014	CcSEcCtD
Cysteamine—Malnutrition—Methotrexate—stomach cancer	0.000397	0.0014	CcSEcCtD
Cysteamine—Vomiting—Fluorouracil—stomach cancer	0.000397	0.00139	CcSEcCtD
Cysteamine—Dyspepsia—Docetaxel—stomach cancer	0.000396	0.00139	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—GAST—stomach cancer	0.000395	0.00139	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—RGS2—stomach cancer	0.000395	0.00139	CbGpPWpGaD
Cysteamine—Rash—Fluorouracil—stomach cancer	0.000393	0.00138	CcSEcCtD
Cysteamine—Dermatitis—Fluorouracil—stomach cancer	0.000393	0.00138	CcSEcCtD
Cysteamine—Decreased appetite—Docetaxel—stomach cancer	0.000391	0.00138	CcSEcCtD
Cysteamine—Headache—Fluorouracil—stomach cancer	0.000391	0.00137	CcSEcCtD
Cysteamine—Urinary tract disorder—Doxorubicin—stomach cancer	0.00039	0.00137	CcSEcCtD
Cysteamine—SST—Signaling Pathways—FGG—stomach cancer	0.00039	0.00138	CbGpPWpGaD
Cysteamine—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000389	0.00137	CcSEcCtD
Cysteamine—Connective tissue disorder—Doxorubicin—stomach cancer	0.000389	0.00137	CcSEcCtD
Cysteamine—Fatigue—Docetaxel—stomach cancer	0.000388	0.00137	CcSEcCtD
Cysteamine—Urethral disorder—Doxorubicin—stomach cancer	0.000388	0.00136	CcSEcCtD
Cysteamine—Nausea—Irinotecan—stomach cancer	0.000387	0.00136	CcSEcCtD
Cysteamine—Immune system disorder—Epirubicin—stomach cancer	0.000386	0.00136	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—ADRB2—stomach cancer	0.000385	0.00136	CbGpPWpGaD
Cysteamine—Constipation—Docetaxel—stomach cancer	0.000385	0.00135	CcSEcCtD
Cysteamine—Dyspepsia—Capecitabine—stomach cancer	0.000384	0.00135	CcSEcCtD
Cysteamine—Decreased appetite—Capecitabine—stomach cancer	0.000379	0.00133	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—PPP2R1A—stomach cancer	0.000378	0.00133	CbGpPWpGaD
Cysteamine—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000376	0.00132	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PRKAA1—stomach cancer	0.000376	0.00133	CbGpPWpGaD
Cysteamine—Fatigue—Capecitabine—stomach cancer	0.000376	0.00132	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—KRAS—stomach cancer	0.000375	0.00132	CbGpPWpGaD
Cysteamine—Mental disorder—Epirubicin—stomach cancer	0.000374	0.00132	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—FGG—stomach cancer	0.000374	0.00132	CbGpPWpGaD
Cysteamine—Constipation—Capecitabine—stomach cancer	0.000373	0.00131	CcSEcCtD
Cysteamine—Erythema—Epirubicin—stomach cancer	0.000372	0.00131	CcSEcCtD
Cysteamine—Malnutrition—Epirubicin—stomach cancer	0.000372	0.00131	CcSEcCtD
Cysteamine—Feeling abnormal—Docetaxel—stomach cancer	0.000371	0.0013	CcSEcCtD
Cysteamine—Nausea—Fluorouracil—stomach cancer	0.00037	0.0013	CcSEcCtD
Cysteamine—MPO—Folate Metabolism—IL6—stomach cancer	0.00037	0.00131	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—ADRB2—stomach cancer	0.00037	0.0013	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Docetaxel—stomach cancer	0.000368	0.00129	CcSEcCtD
Cysteamine—Anaemia—Methotrexate—stomach cancer	0.000367	0.00129	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—IL6—stomach cancer	0.000366	0.00129	CbGpPWpGaD
Cysteamine—Tension—Epirubicin—stomach cancer	0.000365	0.00128	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—TNF—stomach cancer	0.000364	0.00128	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—RBP4—stomach cancer	0.000363	0.00128	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CXCL8—stomach cancer	0.000363	0.00128	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PPP2R1A—stomach cancer	0.000362	0.00128	CbGpPWpGaD
Cysteamine—Nervousness—Epirubicin—stomach cancer	0.000361	0.00127	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PRKAA1—stomach cancer	0.00036	0.00127	CbGpPWpGaD
Cysteamine—Feeling abnormal—Capecitabine—stomach cancer	0.000359	0.00126	CcSEcCtD
Cysteamine—Immune system disorder—Doxorubicin—stomach cancer	0.000357	0.00126	CcSEcCtD
Cysteamine—Gastrointestinal pain—Capecitabine—stomach cancer	0.000356	0.00125	CcSEcCtD
Cysteamine—Abdominal pain—Docetaxel—stomach cancer	0.000356	0.00125	CcSEcCtD
Cysteamine—Body temperature increased—Docetaxel—stomach cancer	0.000356	0.00125	CcSEcCtD
Cysteamine—Leukopenia—Methotrexate—stomach cancer	0.000356	0.00125	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—RBP4—stomach cancer	0.000348	0.00123	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CXCL8—stomach cancer	0.000348	0.00123	CbGpPWpGaD
Cysteamine—Mental disorder—Doxorubicin—stomach cancer	0.000346	0.00122	CcSEcCtD
Cysteamine—Urticaria—Capecitabine—stomach cancer	0.000346	0.00122	CcSEcCtD
Cysteamine—Abdominal pain—Capecitabine—stomach cancer	0.000344	0.00121	CcSEcCtD
Cysteamine—Body temperature increased—Capecitabine—stomach cancer	0.000344	0.00121	CcSEcCtD
Cysteamine—Convulsion—Methotrexate—stomach cancer	0.000344	0.00121	CcSEcCtD
Cysteamine—Malnutrition—Doxorubicin—stomach cancer	0.000344	0.00121	CcSEcCtD
Cysteamine—Erythema—Doxorubicin—stomach cancer	0.000344	0.00121	CcSEcCtD
Cysteamine—Anaemia—Epirubicin—stomach cancer	0.000344	0.00121	CcSEcCtD
Cysteamine—Agitation—Epirubicin—stomach cancer	0.000342	0.0012	CcSEcCtD
Cysteamine—Tension—Doxorubicin—stomach cancer	0.000338	0.00119	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000336	0.00118	CcSEcCtD
Cysteamine—Discomfort—Methotrexate—stomach cancer	0.000334	0.00118	CcSEcCtD
Cysteamine—Nervousness—Doxorubicin—stomach cancer	0.000334	0.00118	CcSEcCtD
Cysteamine—Leukopenia—Epirubicin—stomach cancer	0.000333	0.00117	CcSEcCtD
Cysteamine—Hypersensitivity—Docetaxel—stomach cancer	0.000332	0.00117	CcSEcCtD
Cysteamine—Confusional state—Methotrexate—stomach cancer	0.000327	0.00115	CcSEcCtD
Cysteamine—Anaphylactic shock—Methotrexate—stomach cancer	0.000324	0.00114	CcSEcCtD
Cysteamine—Asthenia—Docetaxel—stomach cancer	0.000323	0.00114	CcSEcCtD
Cysteamine—Convulsion—Epirubicin—stomach cancer	0.000322	0.00113	CcSEcCtD
Cysteamine—Hypertension—Epirubicin—stomach cancer	0.000321	0.00113	CcSEcCtD
Cysteamine—Hypersensitivity—Capecitabine—stomach cancer	0.000321	0.00113	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—HRAS—stomach cancer	0.000319	0.00112	CbGpPWpGaD
Cysteamine—Nervous system disorder—Methotrexate—stomach cancer	0.000318	0.00112	CcSEcCtD
Cysteamine—Anaemia—Doxorubicin—stomach cancer	0.000318	0.00112	CcSEcCtD
Cysteamine—Agitation—Doxorubicin—stomach cancer	0.000316	0.00111	CcSEcCtD
Cysteamine—Skin disorder—Methotrexate—stomach cancer	0.000315	0.00111	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000315	0.00111	CcSEcCtD
Cysteamine—Discomfort—Epirubicin—stomach cancer	0.000313	0.0011	CcSEcCtD
Cysteamine—Asthenia—Capecitabine—stomach cancer	0.000313	0.0011	CcSEcCtD
Cysteamine—SST—Signaling Pathways—HSPB1—stomach cancer	0.000312	0.0011	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AGTR2—stomach cancer	0.000312	0.0011	CbGpPWpGaD
Cysteamine—Anorexia—Methotrexate—stomach cancer	0.000309	0.00109	CcSEcCtD
Cysteamine—SST—Signaling Pathways—BMP2—stomach cancer	0.000309	0.00109	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—F2R—stomach cancer	0.000309	0.00109	CbGpPWpGaD
Cysteamine—Leukopenia—Doxorubicin—stomach cancer	0.000308	0.00108	CcSEcCtD
Cysteamine—Diarrhoea—Docetaxel—stomach cancer	0.000308	0.00108	CcSEcCtD
Cysteamine—Confusional state—Epirubicin—stomach cancer	0.000306	0.00108	CcSEcCtD
Cysteamine—SST—Signaling Pathways—AKR1C3—stomach cancer	0.000304	0.00107	CbGpPWpGaD
Cysteamine—Anaphylactic shock—Epirubicin—stomach cancer	0.000304	0.00107	CcSEcCtD
Cysteamine—SST—Signaling Pathways—HTR1A—stomach cancer	0.0003	0.00106	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HSPB1—stomach cancer	0.000299	0.00106	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AGTR2—stomach cancer	0.000299	0.00106	CbGpPWpGaD
Cysteamine—Convulsion—Doxorubicin—stomach cancer	0.000298	0.00105	CcSEcCtD
Cysteamine—Diarrhoea—Capecitabine—stomach cancer	0.000298	0.00105	CcSEcCtD
Cysteamine—Nervous system disorder—Epirubicin—stomach cancer	0.000298	0.00105	CcSEcCtD
Cysteamine—Dizziness—Docetaxel—stomach cancer	0.000298	0.00105	CcSEcCtD
Cysteamine—Hypertension—Doxorubicin—stomach cancer	0.000297	0.00105	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—BMP2—stomach cancer	0.000296	0.00104	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—F2R—stomach cancer	0.000296	0.00104	CbGpPWpGaD
Cysteamine—Skin disorder—Epirubicin—stomach cancer	0.000295	0.00104	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—IL6—stomach cancer	0.000294	0.00104	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AKR1C3—stomach cancer	0.000291	0.00103	CbGpPWpGaD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000291	0.00102	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—PRKCB—stomach cancer	0.000291	0.00103	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ANXA1—stomach cancer	0.00029	0.00102	CbGpPWpGaD
Cysteamine—Discomfort—Doxorubicin—stomach cancer	0.00029	0.00102	CcSEcCtD
Cysteamine—Anorexia—Epirubicin—stomach cancer	0.000289	0.00102	CcSEcCtD
Cysteamine—Somnolence—Methotrexate—stomach cancer	0.000288	0.00101	CcSEcCtD
Cysteamine—Dizziness—Capecitabine—stomach cancer	0.000288	0.00101	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—HTR1A—stomach cancer	0.000288	0.00102	CbGpPWpGaD
Cysteamine—Vomiting—Docetaxel—stomach cancer	0.000286	0.00101	CcSEcCtD
Cysteamine—Dyspepsia—Methotrexate—stomach cancer	0.000286	0.001	CcSEcCtD
Cysteamine—Rash—Docetaxel—stomach cancer	0.000284	0.000998	CcSEcCtD
Cysteamine—Dermatitis—Docetaxel—stomach cancer	0.000284	0.000997	CcSEcCtD
Cysteamine—Confusional state—Doxorubicin—stomach cancer	0.000283	0.000996	CcSEcCtD
Cysteamine—Decreased appetite—Methotrexate—stomach cancer	0.000282	0.000992	CcSEcCtD
Cysteamine—Headache—Docetaxel—stomach cancer	0.000282	0.000992	CcSEcCtD
Cysteamine—SST—Signaling Pathways—ADRB1—stomach cancer	0.000281	0.000991	CbGpPWpGaD
Cysteamine—Anaphylactic shock—Doxorubicin—stomach cancer	0.000281	0.000988	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Methotrexate—stomach cancer	0.00028	0.000985	CcSEcCtD
Cysteamine—Fatigue—Methotrexate—stomach cancer	0.00028	0.000984	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—PRKCB—stomach cancer	0.000279	0.000984	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ANXA1—stomach cancer	0.000278	0.000981	CbGpPWpGaD
Cysteamine—Vomiting—Capecitabine—stomach cancer	0.000277	0.000975	CcSEcCtD
Cysteamine—Nervous system disorder—Doxorubicin—stomach cancer	0.000275	0.000969	CcSEcCtD
Cysteamine—Rash—Capecitabine—stomach cancer	0.000275	0.000967	CcSEcCtD
Cysteamine—Dermatitis—Capecitabine—stomach cancer	0.000275	0.000966	CcSEcCtD
Cysteamine—Headache—Capecitabine—stomach cancer	0.000273	0.00096	CcSEcCtD
Cysteamine—Skin disorder—Doxorubicin—stomach cancer	0.000273	0.00096	CcSEcCtD
Cysteamine—Somnolence—Epirubicin—stomach cancer	0.00027	0.000949	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—ADRB1—stomach cancer	0.000269	0.00095	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—RPS6—stomach cancer	0.000269	0.000947	CbGpPWpGaD
Cysteamine—Anorexia—Doxorubicin—stomach cancer	0.000268	0.000942	CcSEcCtD
Cysteamine—Nausea—Docetaxel—stomach cancer	0.000267	0.00094	CcSEcCtD
Cysteamine—Feeling abnormal—Methotrexate—stomach cancer	0.000267	0.00094	CcSEcCtD
Cysteamine—Dyspepsia—Epirubicin—stomach cancer	0.000267	0.00094	CcSEcCtD
Cysteamine—Gastrointestinal pain—Methotrexate—stomach cancer	0.000265	0.000933	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—PRKCB—stomach cancer	0.000264	0.000932	CbGpPWpGaD
Cysteamine—Decreased appetite—Epirubicin—stomach cancer	0.000264	0.000928	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—IL6ST—stomach cancer	0.000263	0.000928	CbGpPWpGaD
Cysteamine—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000262	0.000922	CcSEcCtD
Cysteamine—Fatigue—Epirubicin—stomach cancer	0.000262	0.000921	CcSEcCtD
Cysteamine—Constipation—Epirubicin—stomach cancer	0.00026	0.000913	CcSEcCtD
Cysteamine—Nausea—Capecitabine—stomach cancer	0.000259	0.000911	CcSEcCtD
Cysteamine—Urticaria—Methotrexate—stomach cancer	0.000258	0.000907	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—RPS6—stomach cancer	0.000257	0.000908	CbGpPWpGaD
Cysteamine—Body temperature increased—Methotrexate—stomach cancer	0.000256	0.000902	CcSEcCtD
Cysteamine—Abdominal pain—Methotrexate—stomach cancer	0.000256	0.000902	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—PRKCB—stomach cancer	0.000253	0.000893	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL6ST—stomach cancer	0.000252	0.00089	CbGpPWpGaD
Cysteamine—Feeling abnormal—Epirubicin—stomach cancer	0.00025	0.00088	CcSEcCtD
Cysteamine—Somnolence—Doxorubicin—stomach cancer	0.00025	0.000878	CcSEcCtD
Cysteamine—Gastrointestinal pain—Epirubicin—stomach cancer	0.000248	0.000873	CcSEcCtD
Cysteamine—Dyspepsia—Doxorubicin—stomach cancer	0.000247	0.00087	CcSEcCtD
Cysteamine—SST—Signaling Pathways—HBEGF—stomach cancer	0.000247	0.00087	CbGpPWpGaD
Cysteamine—Decreased appetite—Doxorubicin—stomach cancer	0.000244	0.000859	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000243	0.000853	CcSEcCtD
Cysteamine—Fatigue—Doxorubicin—stomach cancer	0.000242	0.000852	CcSEcCtD
Cysteamine—Urticaria—Epirubicin—stomach cancer	0.000241	0.000848	CcSEcCtD
Cysteamine—Constipation—Doxorubicin—stomach cancer	0.00024	0.000845	CcSEcCtD
Cysteamine—Body temperature increased—Epirubicin—stomach cancer	0.00024	0.000844	CcSEcCtD
Cysteamine—Abdominal pain—Epirubicin—stomach cancer	0.00024	0.000844	CcSEcCtD
Cysteamine—Hypersensitivity—Methotrexate—stomach cancer	0.000239	0.000841	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—HBEGF—stomach cancer	0.000237	0.000834	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL6R—stomach cancer	0.000235	0.000828	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—RHOA—stomach cancer	0.000234	0.000824	CbGpPWpGaD
Cysteamine—Asthenia—Methotrexate—stomach cancer	0.000233	0.000819	CcSEcCtD
Cysteamine—Feeling abnormal—Doxorubicin—stomach cancer	0.000231	0.000814	CcSEcCtD
Cysteamine—Gastrointestinal pain—Doxorubicin—stomach cancer	0.00023	0.000808	CcSEcCtD
Cysteamine—SST—Signaling Pathways—ADRB2—stomach cancer	0.000228	0.000803	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL6R—stomach cancer	0.000225	0.000794	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—RHOA—stomach cancer	0.000224	0.00079	CbGpPWpGaD
Cysteamine—Hypersensitivity—Epirubicin—stomach cancer	0.000224	0.000787	CcSEcCtD
Cysteamine—Urticaria—Doxorubicin—stomach cancer	0.000223	0.000785	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PPP2R1A—stomach cancer	0.000223	0.000787	CbGpPWpGaD
Cysteamine—Body temperature increased—Doxorubicin—stomach cancer	0.000222	0.000781	CcSEcCtD
Cysteamine—Abdominal pain—Doxorubicin—stomach cancer	0.000222	0.000781	CcSEcCtD
Cysteamine—Diarrhoea—Methotrexate—stomach cancer	0.000222	0.000781	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—ADRB2—stomach cancer	0.000218	0.00077	CbGpPWpGaD
Cysteamine—Asthenia—Epirubicin—stomach cancer	0.000218	0.000766	CcSEcCtD
Cysteamine—Dizziness—Methotrexate—stomach cancer	0.000215	0.000755	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PPP2R1A—stomach cancer	0.000214	0.000755	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—RHOA—stomach cancer	0.000212	0.000748	CbGpPWpGaD
Cysteamine—Diarrhoea—Epirubicin—stomach cancer	0.000208	0.000731	CcSEcCtD
Cysteamine—SST—Signaling Pathways—SMAD4—stomach cancer	0.000207	0.000731	CbGpPWpGaD
Cysteamine—Hypersensitivity—Doxorubicin—stomach cancer	0.000207	0.000728	CcSEcCtD
Cysteamine—Vomiting—Methotrexate—stomach cancer	0.000206	0.000726	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—CXCL8—stomach cancer	0.000205	0.000723	CbGpPWpGaD
Cysteamine—Rash—Methotrexate—stomach cancer	0.000205	0.00072	CcSEcCtD
Cysteamine—Dermatitis—Methotrexate—stomach cancer	0.000204	0.000719	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—RHOA—stomach cancer	0.000203	0.000717	CbGpPWpGaD
Cysteamine—Headache—Methotrexate—stomach cancer	0.000203	0.000715	CcSEcCtD
Cysteamine—Asthenia—Doxorubicin—stomach cancer	0.000202	0.000709	CcSEcCtD
Cysteamine—Dizziness—Epirubicin—stomach cancer	0.000201	0.000706	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—SMAD4—stomach cancer	0.000199	0.000701	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—FYN—stomach cancer	0.000197	0.000694	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CXCL8—stomach cancer	0.000197	0.000693	CbGpPWpGaD
Cysteamine—Vomiting—Epirubicin—stomach cancer	0.000193	0.000679	CcSEcCtD
Cysteamine—Nausea—Methotrexate—stomach cancer	0.000193	0.000678	CcSEcCtD
Cysteamine—Diarrhoea—Doxorubicin—stomach cancer	0.000192	0.000676	CcSEcCtD
Cysteamine—Rash—Epirubicin—stomach cancer	0.000191	0.000673	CcSEcCtD
Cysteamine—Dermatitis—Epirubicin—stomach cancer	0.000191	0.000673	CcSEcCtD
Cysteamine—Headache—Epirubicin—stomach cancer	0.00019	0.000669	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—FYN—stomach cancer	0.000189	0.000665	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CXCL8—stomach cancer	0.000186	0.000657	CbGpPWpGaD
Cysteamine—Dizziness—Doxorubicin—stomach cancer	0.000186	0.000653	CcSEcCtD
Cysteamine—SST—Signaling Pathways—FGFR2—stomach cancer	0.000185	0.000651	CbGpPWpGaD
Cysteamine—Nausea—Epirubicin—stomach cancer	0.00018	0.000634	CcSEcCtD
Cysteamine—Vomiting—Doxorubicin—stomach cancer	0.000179	0.000628	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—CXCL8—stomach cancer	0.000178	0.000629	CbGpPWpGaD
Cysteamine—Rash—Doxorubicin—stomach cancer	0.000177	0.000623	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—FGFR2—stomach cancer	0.000177	0.000624	CbGpPWpGaD
Cysteamine—Dermatitis—Doxorubicin—stomach cancer	0.000177	0.000622	CcSEcCtD
Cysteamine—Headache—Doxorubicin—stomach cancer	0.000176	0.000619	CcSEcCtD
Cysteamine—SST—Signaling Pathways—IRS2—stomach cancer	0.000169	0.000596	CbGpPWpGaD
Cysteamine—Nausea—Doxorubicin—stomach cancer	0.000167	0.000587	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CAV1—stomach cancer	0.000164	0.000578	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—APOA1—stomach cancer	0.000164	0.000577	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IRS2—stomach cancer	0.000162	0.000572	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CAV1—stomach cancer	0.000157	0.000554	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—APOA1—stomach cancer	0.000157	0.000553	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PRKCB—stomach cancer	0.000156	0.00055	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL6ST—stomach cancer	0.000155	0.000548	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PRKCB—stomach cancer	0.00015	0.000528	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—APC—stomach cancer	0.000149	0.000527	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL6ST—stomach cancer	0.000149	0.000526	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—APC—stomach cancer	0.000143	0.000505	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—MAPK3—stomach cancer	0.000143	0.000504	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL6R—stomach cancer	0.000139	0.000489	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—MAPK3—stomach cancer	0.000137	0.000484	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—MAPK1—stomach cancer	0.000136	0.00048	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—EGFR—stomach cancer	0.000136	0.00048	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL6R—stomach cancer	0.000133	0.000469	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—MAPK1—stomach cancer	0.00013	0.00046	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—EGFR—stomach cancer	0.00013	0.00046	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PIK3CA—stomach cancer	0.00013	0.000459	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SERPINE1—stomach cancer	0.00013	0.000458	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—KRAS—stomach cancer	0.000129	0.000453	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—RHOA—stomach cancer	0.000125	0.000442	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3CA—stomach cancer	0.000125	0.00044	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SERPINE1—stomach cancer	0.000125	0.000439	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NOS3—stomach cancer	0.000124	0.000437	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—KRAS—stomach cancer	0.000123	0.000435	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—RHOA—stomach cancer	0.00012	0.000424	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NOS3—stomach cancer	0.000119	0.000419	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PIK3CA—stomach cancer	0.000118	0.000417	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ERBB2—stomach cancer	0.000116	0.000409	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PIK3CA—stomach cancer	0.000113	0.000399	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ERBB2—stomach cancer	0.000111	0.000392	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CXCL8—stomach cancer	0.00011	0.000388	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—HRAS—stomach cancer	0.000109	0.000385	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CDKN1B—stomach cancer	0.000107	0.000379	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CXCL8—stomach cancer	0.000105	0.000372	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—HRAS—stomach cancer	0.000105	0.000369	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL6—stomach cancer	0.000105	0.000369	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CDKN1B—stomach cancer	0.000103	0.000363	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCND1—stomach cancer	0.000102	0.000361	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—JUN—stomach cancer	0.000102	0.000361	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL6—stomach cancer	0.0001	0.000354	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MMP9—stomach cancer	9.95e-05	0.000351	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CDKN1A—stomach cancer	9.91e-05	0.00035	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCND1—stomach cancer	9.82e-05	0.000346	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—JUN—stomach cancer	9.8e-05	0.000346	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MAPK8—stomach cancer	9.67e-05	0.000341	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MMP9—stomach cancer	9.54e-05	0.000336	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CDKN1A—stomach cancer	9.5e-05	0.000335	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MAPK8—stomach cancer	9.28e-05	0.000327	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—VEGFA—stomach cancer	8.93e-05	0.000315	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—STAT3—stomach cancer	8.84e-05	0.000312	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—VEGFA—stomach cancer	8.56e-05	0.000302	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—STAT3—stomach cancer	8.48e-05	0.000299	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MAPK3—stomach cancer	8.45e-05	0.000298	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MYC—stomach cancer	8.22e-05	0.00029	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MAPK3—stomach cancer	8.1e-05	0.000286	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MAPK1—stomach cancer	8.04e-05	0.000284	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EGFR—stomach cancer	8.04e-05	0.000283	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MYC—stomach cancer	7.88e-05	0.000278	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MAPK1—stomach cancer	7.71e-05	0.000272	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—EGFR—stomach cancer	7.71e-05	0.000272	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—KRAS—stomach cancer	7.59e-05	0.000268	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—KRAS—stomach cancer	7.28e-05	0.000257	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PIK3CA—stomach cancer	6.98e-05	0.000246	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TP53—stomach cancer	6.75e-05	0.000238	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PIK3CA—stomach cancer	6.69e-05	0.000236	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TP53—stomach cancer	6.47e-05	0.000228	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HRAS—stomach cancer	6.45e-05	0.000228	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HRAS—stomach cancer	6.19e-05	0.000218	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL6—stomach cancer	6.18e-05	0.000218	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL6—stomach cancer	5.92e-05	0.000209	CbGpPWpGaD
